A citation-based method for searching scientific literature

A John Rush, Madhukar H Trivedi, Stephen R Wisniewski, Andrew A Nierenberg, Jonathan W Stewart, Diane Warden, George Niederehe, Michael E Thase, Philip W Lavori, Barry D Lebowitz, Patrick J McGrath, Jerrold F Rosenbaum, Harold A Sackeim, David J Kupfer, James Luther, Maurizio Fava. Am J Psychiatry 2006
Times Cited: 2599







List of co-cited articles
605 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
Madhukar H Trivedi, A John Rush, Stephen R Wisniewski, Andrew A Nierenberg, Diane Warden, Louise Ritz, Grayson Norquist, Robert H Howland, Barry Lebowitz, Patrick J McGrath,[...]. Am J Psychiatry 2006
15

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins,[...]. Lancet 2018
803
15


A rating scale for depression.
M HAMILTON. J Neurol Neurosurg Psychiatry 1960
11

Antidepressant effects of ketamine in depressed patients.
R M Berman, A Cappiello, A Anand, D A Oren, G R Heninger, D S Charney, J H Krystal. Biol Psychiatry 2000
10

The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.
A John Rush, Madhukar H Trivedi, Hicham M Ibrahim, Thomas J Carmody, Bruce Arnow, Daniel N Klein, John C Markowitz, Philip T Ninan, Susan Kornstein, Rachel Manber,[...]. Biol Psychiatry 2003
9

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.
Ronald S Duman, George K Aghajanian, Gerard Sanacora, John H Krystal. Nat Med 2016
565
9


A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Carlos A Zarate, Jaskaran B Singh, Paul J Carlson, Nancy E Brutsche, Rezvan Ameli, David A Luckenbaugh, Dennis S Charney, Husseini K Manji. Arch Gen Psychiatry 2006
8

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Panos Zanos, Ruin Moaddel, Patrick J Morris, Polymnia Georgiou, Jonathan Fischell, Greg I Elmer, Manickavasagom Alkondon, Peixiong Yuan, Heather J Pribut, Nagendra S Singh,[...]. Nature 2016
715
7

Mechanisms of ketamine action as an antidepressant.
P Zanos, T D Gould. Mol Psychiatry 2018
227
7

Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
John P O'Reardon, H Brent Solvason, Philip G Janicak, Shirlene Sampson, Keith E Isenberg, Ziad Nahas, William M McDonald, David Avery, Paul B Fitzgerald, Colleen Loo,[...]. Biol Psychiatry 2007
862
6


Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.
G Rajkowska, J J Miguel-Hidalgo, J Wei, G Dilley, S D Pittman, H Y Meltzer, J C Overholser, B L Roth, C A Stockmeier. Biol Psychiatry 1999
6

A meta-analysis of cytokines in major depression.
Yekta Dowlati, Nathan Herrmann, Walter Swardfager, Helena Liu, Lauren Sham, Elyse K Reim, Krista L Lanctôt. Biol Psychiatry 2010
6

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
James W Murrough, Dan V Iosifescu, Lee C Chang, Rayan K Al Jurdi, Charles E Green, Andrew M Perez, Syed Iqbal, Sarah Pillemer, Alexandra Foulkes, Asim Shah,[...]. Am J Psychiatry 2013
601
6

Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial.
Ella J Daly, Jaskaran B Singh, Maggie Fedgchin, Kimberly Cooper, Pilar Lim, Richard C Shelton, Michael E Thase, Andrew Winokur, Luc Van Nueten, Husseini Manji,[...]. JAMA Psychiatry 2018
221
6

Decreased expression of synapse-related genes and loss of synapses in major depressive disorder.
Hyo Jung Kang, Bhavya Voleti, Tibor Hajszan, Grazyna Rajkowska, Craig A Stockmeier, Pawel Licznerski, Ashley Lepack, Mahesh S Majik, Lak Shin Jeong, Mounira Banasr,[...]. Nat Med 2012
381
6

The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).
Ronald C Kessler, Patricia Berglund, Olga Demler, Robert Jin, Doreen Koretz, Kathleen R Merikangas, A John Rush, Ellen E Walters, Philip S Wang. JAMA 2003
5

Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis.
Andre R Brunoni, Anna Chaimani, Adriano H Moffa, Lais B Razza, Wagner F Gattaz, Zafiris J Daskalakis, Andre F Carvalho. JAMA Psychiatry 2017
171
5

Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine.
Marc S Lener, Mark J Niciu, Elizabeth D Ballard, Minkyung Park, Lawrence T Park, Allison C Nugent, Carlos A Zarate. Biol Psychiatry 2017
156
5

Depression.
Gin S Malhi, J John Mann. Lancet 2018
448
5

A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013.
David A Mrazek, John C Hornberger, C Anthony Altar, Irina Degtiar. Psychiatr Serv 2014
242
5

Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate.
Michael D Fox, Randy L Buckner, Matthew P White, Michael D Greicius, Alvaro Pascual-Leone. Biol Psychiatry 2012
427
5

Theta burst stimulation of the human motor cortex.
Ying-Zu Huang, Mark J Edwards, Elisabeth Rounis, Kailash P Bhatia, John C Rothwell. Neuron 2005
5

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists.
Nanxin Li, Boyoung Lee, Rong-Jian Liu, Mounira Banasr, Jason M Dwyer, Masaaki Iwata, Xiao-Yuan Li, George Aghajanian, Ronald S Duman. Science 2010
5


The economic burden of adults with major depressive disorder in the United States (2005 and 2010).
Paul E Greenberg, Andree-Anne Fournier, Tammy Sisitsky, Crystal T Pike, Ronald C Kessler. J Clin Psychiatry 2015
734
5

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological Treatments.
Sidney H Kennedy, Raymond W Lam, Roger S McIntyre, S Valérie Tourjman, Venkat Bhat, Pierre Blier, Mehrul Hasnain, Fabrice Jollant, Anthony J Levitt, Glenda M MacQueen,[...]. Can J Psychiatry 2016
353
5

Major depressive disorder.
Christian Otte, Stefan M Gold, Brenda W Penninx, Carmine M Pariante, Amit Etkin, Maurizio Fava, David C Mohr, Alan F Schatzberg. Nat Rev Dis Primers 2016
426
5

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Vanina Popova, Ella J Daly, Madhukar Trivedi, Kimberly Cooper, Rosanne Lane, Pilar Lim, Christine Mazzucco, David Hough, Michael E Thase, Richard C Shelton,[...]. Am J Psychiatry 2019
149
5

Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study.
Carla M Canuso, Jaskaran B Singh, Maggie Fedgchin, Larry Alphs, Rosanne Lane, Pilar Lim, Christine Pinter, David Hough, Gerard Sanacora, Husseini Manji,[...]. Am J Psychiatry 2018
159
5

Deep brain stimulation for treatment-resistant depression.
Helen S Mayberg, Andres M Lozano, Valerie Voon, Heather E McNeely, David Seminowicz, Clement Hamani, Jason M Schwalb, Sidney H Kennedy. Neuron 2005
5

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.
Andrew H Miller, Vladimir Maletic, Charles L Raison. Biol Psychiatry 2009
4

Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.
Daniel Souery, Pierre Oswald, Isabelle Massat, Ursula Bailer, Joseph Bollen, Koen Demyttenaere, Siegfried Kasper, Yves Lecrubier, Stuart Montgomery, Alessandro Serretti,[...]. J Clin Psychiatry 2007
291
4


Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.
Annamaria Cattaneo, Massimo Gennarelli, Rudolf Uher, Gerome Breen, Anne Farmer, Katherine J Aitchison, Ian W Craig, Christoph Anacker, Patricia A Zunsztain, Peter McGuffin,[...]. Neuropsychopharmacology 2013
263
4


The Role of Neural Plasticity in Depression: From Hippocampus to Prefrontal Cortex.
Wei Liu, Tongtong Ge, Yashu Leng, Zhenxiang Pan, Jie Fan, Wei Yang, Ranji Cui. Neural Plast 2017
188
4


Resting-state connectivity biomarkers define neurophysiological subtypes of depression.
Andrew T Drysdale, Logan Grosenick, Jonathan Downar, Katharine Dunlop, Farrokh Mansouri, Yue Meng, Robert N Fetcho, Benjamin Zebley, Desmond J Oathes, Amit Etkin,[...]. Nat Med 2017
745
4

Large-Scale Network Dysfunction in Major Depressive Disorder: A Meta-analysis of Resting-State Functional Connectivity.
Roselinde H Kaiser, Jessica R Andrews-Hanna, Tor D Wager, Diego A Pizzagalli. JAMA Psychiatry 2015
757
4

Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
Daniel M Blumberger, Fidel Vila-Rodriguez, Kevin E Thorpe, Kfir Feffer, Yoshihiro Noda, Peter Giacobbe, Yuliya Knyahnytska, Sidney H Kennedy, Raymond W Lam, Zafiris J Daskalakis,[...]. Lancet 2018
253
4


Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression.
Eleanor J Cole, Katy H Stimpson, Brandon S Bentzley, Merve Gulser, Kirsten Cherian, Claudia Tischler, Romina Nejad, Heather Pankow, Elizabeth Choi, Haley Aaron,[...]. Am J Psychiatry 2020
46
8

Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression.
Naomi R Wray, Stephan Ripke, Manuel Mattheisen, Maciej Trzaskowski, Enda M Byrne, Abdel Abdellaoui, Mark J Adams, Esben Agerbo, Tracy M Air, Till M F Andlauer,[...]. Nat Genet 2018
865
4

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Ella J Daly, Madhukar H Trivedi, Adam Janik, Honglan Li, Yun Zhang, Xiang Li, Rosanne Lane, Pilar Lim, Anna R Duca, David Hough,[...]. JAMA Psychiatry 2019
115
4

NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses.
Anita E Autry, Megumi Adachi, Elena Nosyreva, Elisa S Na, Maarten F Los, Peng-fei Cheng, Ege T Kavalali, Lisa M Monteggia. Nature 2011
4

Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation.
R N Moda-Sava, M H Murdock, P K Parekh, R N Fetcho, B S Huang, T N Huynh, J Witztum, D C Shaver, D L Rosenthal, E J Alway,[...]. Science 2019
159
4

The use of ketamine as an antidepressant: a systematic review and meta-analysis.
Caoimhe M Coyle, Keith R Laws. Hum Psychopharmacol 2015
138
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.